Protegrins: new antibiotics of mammalian origin

Bibliography

• Antimicrobial Peptides. Marsh J, Goode JA (Eds.), John Wiley & Sons Ltd., Chichester, UK (1994).
   Google Scholar
• GANZ T, LEHRER RI: Antimicrobial peptides of leukocytes. Curr. Opin. Hematol (1997) 4:53–58.
   PubMedGoogle Scholar
• HUTTNER KM, BEVINS CL: Antimicrobial peptides as mediators of epithelial host defense. Pediatr. Res. (1999) 45:785–794.
   PubMed Web of Science ®Google Scholar
• MERRIFIELD RB, VIZIOLI LD, BOMAN HG: Synthesis ofthe antibacterial peptide cecropin A (1-33). Biochem-istry (1982) 21:5020–5031.
   PubMed Web of Science ®Google Scholar
• WILLIAMS RW, STARMAN R, TAYLOR KM et al.: Ramanspectroscopy of synthetic antimicrobial frog peptides magainin 2a and PGLa. Biochemistry (1990) 29:4490–4496.
   PubMed Web of Science ®Google Scholar
• HILL CP, YEE J, SELSTED ME, EISENBERG D: Crystalstructure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science (1991) 251:1481–1485.
   PubMed Web of Science ®Google Scholar
• MARTIN E, GANZ T, LEHRER RI: Defensins and otherendogenous peptide antibiotics of vertebrates. J. Leukoc. Biol. (1995) 58:128–136.
   PubMed Web of Science ®Google Scholar
• ZANETTI M, GENNARO R, ROMEO D: Cathelicidins: anovel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. (1995) 374:1–5.
   PubMed Web of Science ®Google Scholar
• KOKRYAKOV VN, HARWIG SS, PANYUTICH EA et al.:Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett. (1993) 327:231–236.
   PubMed Web of Science ®Google Scholar
• AUMELAS A, MANGONI M, ROUMESTAND C et al.: Synthesis and solution structure of the antimicrobial peptide protegrin-1. Eur.J. Biochem. (1996) 237:575–583.
   PubMedGoogle Scholar
• FAHRNER RL, DIECKMANN T, HARWIG SS et al.: Solution structure of protegrin-1, a broad-spectrum antimicro-bial peptide from porcine leukocytes. Chem. Biol. (1996) 3:543–550.
   PubMed Web of Science ®Google Scholar
• TANG YQ, YUAN J, OSAPAY G et al.: A cyclic antimicro-bial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science (1999) 286:498–502.
   PubMed Web of Science ®Google Scholar
• NAKAMURA T, FURUNAKA H, MIYATA T et al.: Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus triden-tatus). Isolation and chemical structure. J. Biol. Chem. (1988) 263:16709–16713.
   PubMed Web of Science ®Google Scholar
• PARK NG, LEE S, OISHI 0 et al.: Conformation oftachyplesin I from Tachypleus tridentatus when interacting with lipid matrices. Biochemistry (1992) 31:12241–12247.
   Google Scholar
• ZHAO C, LIU L, LEHRER RI: Identification of a new member of the protegrin family by cDNA cloning. FEBS Lett. (1994) 346:285–288.
   PubMed Web of Science ®Google Scholar
• ZHAO C, GANZ T, LEHRER RI: The structure of porcine protegrin genes. FEBS Lett. (1995) 368:197–202.
   PubMed Web of Science ®Google Scholar
• PANYUTICH A, SHI J, BOUTZ PL, ZHAO C, GANZ T: Porcine polymorphonuclear leukocytes generate ex tr acellular microbicidal activity by elastase-mediated activation of secreted proprotegrins. Infect. Immun. (1997) 65:978–985.
   PubMed Web of Science ®Google Scholar
• SCOCCHI M, SKERLAVAJ B, ROMEO D, GENNARO R: Proteolytic cleavage by neutrophil elastase converts inactive storage proforms to antibacterial bactenecins. Eur. j Biochem. (1992) 209:589–595.
   PubMedGoogle Scholar
• SHI J, GANZ T: The role of protegrins and other elastase-activated p olypep tides in the bactericidal properties of porcine inflammatory fluids. Infect. Immun. (1998) 66:3611–3617.
   PubMed Web of Science ®Google Scholar
• CHEN J, FALLA TJ, LIU H et al.: Development ofprotegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic pr o tegr in analogs. Biopolymers. (In Press).
   Google Scholar
• QU XD, HARWIG SSL, OREN A, SHAFER WM, LEHRER RI: Susceptibility of Neisseria gonorrhoeae to protegrins. Infect. Immun. (1996) 64: 1240–1245.
   PubMed Web of Science ®Google Scholar
• QU XD, HARWIG SSL, SHAFER WM, LEHRER RI: Pr otegrin structure and activity against Neisseria gonorrhoeae. Infect. Immun. (1996) 65: 636–639.
   Web of Science ®Google Scholar
• YASIN B., HARWIG SSL, LEHRER RI, WAGAR EA: Suscepti-bility of Chlamydia trachomatis to protegrins and defensins. Infect. Immun. (1996) 64:709–713.
   PubMed Web of Science ®Google Scholar
• YASIN B, LEHRER RI, HARWIG SSL, WAGAR EA: Protegrins: structural requirements for inactivating elementary bodies of Chlamydia trachomatis. Infect. Immun. (1996) 64: 4863–4866.
   PubMed Web of Science ®Google Scholar
• FORTNEY K, TOTTEN PA, LEHRER RI, SPINOLA SM: Haemophilus ducreyi is susceptible to protegrin. Antimicrob. Agents Chemother. (1998) 42:2690–2693.
   PubMed Web of Science ®Google Scholar
• TAMAMURA H, MURAKAMI T, HORIUCHI S et al.: Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity. Chem. Pharm. Bull. (Tokyo) (1995) 43:853–858.
   PubMed Web of Science ®Google Scholar
• YASIN B, PANG M, TURNER J et al.: Evaluation of the inactivation of infectious herpes simplex virus by host-defense peptides. Eur.J. Clin. Microbiol Infect. Dis. (2000) 19:187–194.
   PubMed Web of Science ®Google Scholar
• LILJEMARK WF, BLOOMQUIST CG: Normal microbial flora of the human body. In: Oral Microbiology and Immunology. Nisengard RJ, Newman MB (Eds.), WB Saunders Co., Philadelphia, PA, USA (1994):120–128.
   Google Scholar
• LOESCHE WJ: Ecology of the oral flora. In: Oral Microbi-ology and Immunology. Nisengard RJ, Newman MB (Eds.), WB Saunders Co., Philadelphia, PA, USA (1994):307–315.
   Google Scholar
• LOURY DJ, EMBREE JR, STEINBERG DA, SONIS ST, FIDDES JC: Effect of local application of the antimicrobial peptide IB-367 on the incidence and severity of oral mucositis in hamsters. Oral Surg. Oral Med. Oral Pathol. Oral Radio]. Endod. (1999) 87:544–551.
   PubMed Web of Science ®Google Scholar
• BEARMAN SI, APPELBAUM FR, BUCKNER CD et al.: Regimen-related toxicity in patients undergoing bone marrow transplantation. J. Clin. Oncof (1988) 6:1562–1568.
   PubMed Web of Science ®Google Scholar
• BELLM LA, EPSTEIN JB, ROSE-PED A, MARTIN P, FUCHS HJ: Patient reports of complications of bone marrow transplantation. Support. Care Cancer (2000) 8:33–39.
   PubMed Web of Science ®Google Scholar
• COX JD, PAJAK TF, MARCIAL VA et al.: Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. Cancer (1992) 69:2744–2748.
   PubMed Web of Science ®Google Scholar
• SPIJKERVET FKL, VAN SAENE HKF, VAN SAENE JJM, PANDERS AK, VERMEY A, MEHTA DM: Mucositis prevented by selective elimination of oral flora in irradiated head and neck cancer patients. j Oral. Pathol Med. (1991) 19:486–489.
   Web of Science ®Google Scholar
• SYMONDS RP, McILROY P, KHORRAMI J et al.: The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled double-blind trial. Br. J. Cancer (1996) 74:312–317.
   PubMed Web of Science ®Google Scholar
• SONIS ST: Phase IB safety study of IB-367 given to patients receiving myeloablative chemotherapy who are undergoing bone marrow or peripheral blood stem cell transplantation and at risk for developing oral mucositis. Tandem BMT Meeting. Keystone, USA (1999):40.
   Google Scholar
• SONIS ST, EILERS JP, EPSTEIN JB et al.: Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Cancer (1999) 85:2103–2113.
   PubMed Web of Science ®Google Scholar
• VESOLE DH, FUCH HJ: IB-367 reduces the number of days of severe oral mucositis complicating myeloabla-tive chemotherapy. The American Society of Hematology 41st Annual Meeting. New Orleans, USA (1999):154a.
   Google Scholar
• ABELE-HORN M, DAUBER A, BAUERNFEIND A et al.: Decrease in Nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination. Intensive Care Med. (1997) 23:187–195.
   PubMed Web of Science ®Google Scholar